| Identification | Back Directory | [Name]
PFE-360 | [CAS]
1527475-61-1 | [Synonyms]
PFE-360
PF-06685360
1H-Pyrrole-2-carbonitrile, 1-methyl-4-[4-(4-morpholinyl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]- | [Molecular Formula]
C16H16N6O | [MOL File]
1527475-61-1.mol | [Molecular Weight]
308.34 |
| Hazard Information | Back Directory | [Description]
PFE-360 (PF-06685360) is a poten and elective inhibitor of LRRK2 kinase. | [in vitro]
PFE-360 (4 mg/kg and 7.5 mg/kg, orally, BID, 10-12 weeks) treatment potently decreases the LRRK2-pSer935/total LRRK2 ratio, with no significant adverse effects.
animal Model: Female Sprague Dawley rats (NTac:SD) weighed 225-250 g.
Dosage: 4 mg/kg and 7.5 mg/kg (pharmacokinetics and pharmacodynamics).
Administration: Orally BID for 10-12 weeks.
Result: The LRRK2-pSer935/total LRRK2 ratio was significantly decreased at both 1 h and 12 h after dosing.
The terminal bodyweights exhibited no significant changes. | [storage]
Store at -20°C |
|
| Company Name: |
guoyungurui
|
| Tel: |
18162595016 |
| Website: |
www.chemicalbook.com/supplier/25521782/ |
|